Symbol="PIRS"
AssetType="Common Stock"
Name="Pieris Pharmaceuticals Inc"
Description="Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anti-calcium protein-based drugs in the United States. The company is headquartered in Boston, Massachusetts."
CIK="1583648"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="255 STATE STREET, 9TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18478900"
EBITDA="-34430000"
PERatio="None"
PEGRatio="0"
BookValue="0.41"
DividendPerShare="0"
DividendYield="0"
EPS="-0.55"
RevenuePerShareTTM="0.427"
ProfitMargin="-0.814"
OperatingMarginTTM="-1.118"
ReturnOnAssetsTTM="-0.23"
ReturnOnEquityTTM="-0.637"
RevenueTTM="33207000"
GrossProfitTTM="-27080000"
DilutedEPSTTM="-0.55"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.423"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.596"
PriceToBookRatio="2.08"
EVToRevenue="0.589"
EVToEBITDA="-0.49"
Beta="0.835"
num_52WeekHigh="1.97"
num_52WeekLow="0.162"
num_50DayMovingAverage="0.386"
num_200DayMovingAverage="0.946"
SharesOutstanding="82019000"
DividendDate="None"
ExDividendDate="None"
symbol="PIRS"
open="0.24"
high="0.25"
low="0.22"
price="0.23"
volume="1059627.00"
latest_trading_day="2023-08-14"
previous_close="0.24"
change="-0.00"
change_percent="-1.4774%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="94"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="1950640"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.6"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="526"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="695"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0013.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
